 | • レポートコード：D0GIR-01473 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、夜間頻尿の世界市場を広く調査・分析し、今後の市場展望をまとめております。夜間頻尿の種類別市場規模（抗コリン薬、デスモプレシン、抗生物質、鎮痙薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Allergan、Glenmark Pharmaceuticals、Urigen Pharmaceuticals、Avadel Pharmaceuticals、Ferring Pharmaceuticals、AA Pharma、Teva Pharmaceutical Industries ・地域別グローバル市場分析 2015年-2020年 ・夜間頻尿の北米市場（アメリカ、カナダ、メキシコ） ・夜間頻尿のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・夜間頻尿のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・夜間頻尿の南米市場（ブラジル、アルゼンチン） ・夜間頻尿の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：抗コリン薬、デスモプレシン、抗生物質、鎮痙薬、その他 ・用途別分析：病院薬局、小売薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Nocturia market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.2% in the forecast period of 2020 to 2025 and will expected to reach USD 2669.5 million by 2025, from USD 2098.5 million in 2019.
The Nocturia market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Nocturia market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nocturia market has been segmented into:
Anticholinergic Drugs
Desmopressin
Antibiotics
Antispasmodic
Others
By Application, Nocturia has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nocturia market presented in the report. This section sheds light on the sales growth of different regional and country-level Nocturia markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nocturia market.
The report offers in-depth assessment of the growth and other aspects of the Nocturia market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Nocturia Market Share Analysis
Nocturia competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nocturia sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nocturia sales, revenue and market share for each player covered in this report.
The major players covered in Nocturia are:
Allergan
Glenmark Pharmaceuticals
Urigen Pharmaceuticals
Avadel Pharmaceuticals
Ferring Pharmaceuticals
AA Pharma
Teva Pharmaceutical Industries
Table of Contents
1 Nocturia Market Overview
1.1 Product Overview and Scope of Nocturia
1.2 Classification of Nocturia by Type
1.2.1 Global Nocturia Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Nocturia Revenue Market Share by Type in 2019
1.2.3 Anticholinergic Drugs
1.2.4 Desmopressin
1.2.5 Antibiotics
1.2.6 Antispasmodic
1.2.7 Others
1.3 Global Nocturia Market by Application
1.3.1 Overview: Global Nocturia Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Nocturia Market by Regions
1.4.1 Global Nocturia Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Nocturia (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Nocturia Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Nocturia Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nocturia Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Nocturia Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nocturia Status and Prospect (2015-2025)
2 Company Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Allergan SWOT Analysis
2.1.4 Allergan Product and Services
2.1.5 Allergan Nocturia Revenue, Gross Margin and Market Share (2018-2019)
2.2 Glenmark Pharmaceuticals
2.2.1 Glenmark Pharmaceuticals Details
2.2.2 Glenmark Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Glenmark Pharmaceuticals SWOT Analysis
2.2.4 Glenmark Pharmaceuticals Product and Services
2.2.5 Glenmark Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2018-2019)
2.3 Urigen Pharmaceuticals
2.3.1 Urigen Pharmaceuticals Details
2.3.2 Urigen Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Urigen Pharmaceuticals SWOT Analysis
2.3.4 Urigen Pharmaceuticals Product and Services
2.3.5 Urigen Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2018-2019)
2.4 Avadel Pharmaceuticals
2.4.1 Avadel Pharmaceuticals Details
2.4.2 Avadel Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Avadel Pharmaceuticals SWOT Analysis
2.4.4 Avadel Pharmaceuticals Product and Services
2.4.5 Avadel Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ferring Pharmaceuticals
2.5.1 Ferring Pharmaceuticals Details
2.5.2 Ferring Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Ferring Pharmaceuticals SWOT Analysis
2.5.4 Ferring Pharmaceuticals Product and Services
2.5.5 Ferring Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2018-2019)
2.6 AA Pharma
2.6.1 AA Pharma Details
2.6.2 AA Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AA Pharma SWOT Analysis
2.6.4 AA Pharma Product and Services
2.6.5 AA Pharma Nocturia Revenue, Gross Margin and Market Share (2018-2019)
2.7 Teva Pharmaceutical Industries
2.7.1 Teva Pharmaceutical Industries Details
2.7.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Teva Pharmaceutical Industries SWOT Analysis
2.7.4 Teva Pharmaceutical Industries Product and Services
2.7.5 Teva Pharmaceutical Industries Nocturia Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Nocturia Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Nocturia Players Market Share
3.2.2 Top 10 Nocturia Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Nocturia Revenue and Market Share by Regions
4.2 North America Nocturia Revenue and Growth Rate (2015-2020)
4.3 Europe Nocturia Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Nocturia Revenue and Growth Rate (2015-2020)
4.5 South America Nocturia Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Nocturia Revenue and Growth Rate (2015-2020)
5 North America Nocturia Revenue by Countries
5.1 North America Nocturia Revenue by Countries (2015-2020)
5.2 USA Nocturia Revenue and Growth Rate (2015-2020)
5.3 Canada Nocturia Revenue and Growth Rate (2015-2020)
5.4 Mexico Nocturia Revenue and Growth Rate (2015-2020)
6 Europe Nocturia Revenue by Countries
6.1 Europe Nocturia Revenue by Countries (2015-2020)
6.2 Germany Nocturia Revenue and Growth Rate (2015-2020)
6.3 UK Nocturia Revenue and Growth Rate (2015-2020)
6.4 France Nocturia Revenue and Growth Rate (2015-2020)
6.5 Russia Nocturia Revenue and Growth Rate (2015-2020)
6.6 Italy Nocturia Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Nocturia Revenue by Countries
7.1 Asia-Pacific Nocturia Revenue by Countries (2015-2020)
7.2 China Nocturia Revenue and Growth Rate (2015-2020)
7.3 Japan Nocturia Revenue and Growth Rate (2015-2020)
7.4 Korea Nocturia Revenue and Growth Rate (2015-2020)
7.5 India Nocturia Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Nocturia Revenue and Growth Rate (2015-2020)
8 South America Nocturia Revenue by Countries
8.1 South America Nocturia Revenue by Countries (2015-2020)
8.2 Brazil Nocturia Revenue and Growth Rate (2015-2020)
8.3 Argentina Nocturia Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Nocturia by Countries
9.1 Middle East & Africa Nocturia Revenue by Countries (2015-2020)
9.2 Saudi Arabia Nocturia Revenue and Growth Rate (2015-2020)
9.3 UAE Nocturia Revenue and Growth Rate (2015-2020)
9.4 Egypt Nocturia Revenue and Growth Rate (2015-2020)
9.5 South Africa Nocturia Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Nocturia Revenue and Market Share by Type (2015-2020)
10.2 Global Nocturia Market Forecast by Type (2019-2024)
10.3 Anticholinergic Drugs Revenue Growth Rate (2015-2025)
10.4 Desmopressin Revenue Growth Rate (2015-2025)
10.5 Antibiotics Revenue Growth Rate (2015-2025)
10.6 Antispasmodic Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Nocturia Market Segment by Application
11.1 Global Nocturia Revenue Market Share by Application (2015-2020)
11.2 Nocturia Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
11.5 Online Pharmacies Revenue Growth (2015-2020)
12 Global Nocturia Market Size Forecast (2021-2025)
12.1 Global Nocturia Market Size Forecast (2021-2025)
12.2 Global Nocturia Market Forecast by Regions (2021-2025)
12.3 North America Nocturia Revenue Market Forecast (2021-2025)
12.4 Europe Nocturia Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Nocturia Revenue Market Forecast (2021-2025)
12.6 South America Nocturia Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Nocturia Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Nocturia Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nocturia by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nocturia Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Nocturia Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Allergan Corporate Information, Location and Competitors
Table 6. Allergan Nocturia Major Business
Table 7. Allergan Nocturia Total Revenue (USD Million) (2017-2018)
Table 8. Allergan SWOT Analysis
Table 9. Allergan Nocturia Product and Solutions
Table 10. Allergan Nocturia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Glenmark Pharmaceuticals Corporate Information, Location and Competitors
Table 12. Glenmark Pharmaceuticals Nocturia Major Business
Table 13. Glenmark Pharmaceuticals Nocturia Total Revenue (USD Million) (2018-2019)
Table 14. Glenmark Pharmaceuticals SWOT Analysis
Table 15. Glenmark Pharmaceuticals Nocturia Product and Solutions
Table 16. Glenmark Pharmaceuticals Nocturia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Urigen Pharmaceuticals Corporate Information, Location and Competitors
Table 18. Urigen Pharmaceuticals Nocturia Major Business
Table 19. Urigen Pharmaceuticals Nocturia Total Revenue (USD Million) (2017-2018)
Table 20. Urigen Pharmaceuticals SWOT Analysis
Table 21. Urigen Pharmaceuticals Nocturia Product and Solutions
Table 22. Urigen Pharmaceuticals Nocturia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Avadel Pharmaceuticals Corporate Information, Location and Competitors
Table 24. Avadel Pharmaceuticals Nocturia Major Business
Table 25. Avadel Pharmaceuticals Nocturia Total Revenue (USD Million) (2017-2018)
Table 26. Avadel Pharmaceuticals SWOT Analysis
Table 27. Avadel Pharmaceuticals Nocturia Product and Solutions
Table 28. Avadel Pharmaceuticals Nocturia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Ferring Pharmaceuticals Corporate Information, Location and Competitors
Table 30. Ferring Pharmaceuticals Nocturia Major Business
Table 31. Ferring Pharmaceuticals Nocturia Total Revenue (USD Million) (2017-2018)
Table 32. Ferring Pharmaceuticals SWOT Analysis
Table 33. Ferring Pharmaceuticals Nocturia Product and Solutions
Table 34. Ferring Pharmaceuticals Nocturia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. AA Pharma Corporate Information, Location and Competitors
Table 36. AA Pharma Nocturia Major Business
Table 37. AA Pharma Nocturia Total Revenue (USD Million) (2017-2018)
Table 38. AA Pharma SWOT Analysis
Table 39. AA Pharma Nocturia Product and Solutions
Table 40. AA Pharma Nocturia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Teva Pharmaceutical Industries Corporate Information, Location and Competitors
Table 42. Teva Pharmaceutical Industries Nocturia Major Business
Table 43. Teva Pharmaceutical Industries Nocturia Total Revenue (USD Million) (2017-2018)
Table 44. Teva Pharmaceutical Industries SWOT Analysis
Table 45. Teva Pharmaceutical Industries Nocturia Product and Solutions
Table 46. Teva Pharmaceutical Industries Nocturia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Nocturia Revenue (Million USD) by Players (2015-2020)
Table 48. Global Nocturia Revenue Share by Players (2015-2020)
Table 49. Global Nocturia Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Nocturia Revenue Market Share by Regions (2015-2020)
Table 51. North America Nocturia Revenue by Countries (2015-2020)
Table 52. North America Nocturia Revenue Market Share by Countries (2015-2020)
Table 53. Europe Nocturia Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Nocturia Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Nocturia Revenue by Countries (2015-2020)
Table 56. South America Nocturia Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Nocturia Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Nocturia Revenue Market Share by Countries (2015-2020)
Table 59. Global Nocturia Revenue (Million USD) by Type (2015-2020)
Table 60. Global Nocturia Revenue Share by Type (2015-2020)
Table 61. Global Nocturia Revenue Forecast by Type (2021-2025)
Table 62. Global Nocturia Revenue by Application (2015-2020)
Table 63. Global Nocturia Revenue Share by Application (2015-2020)
Table 64. Global Nocturia Revenue Forecast by Application (2021-2025)
Table 65. Global Nocturia Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Nocturia Picture
Figure 2. Global Nocturia Revenue Market Share by Type in 2019
Figure 3. Anticholinergic Drugs Picture
Figure 4. Desmopressin Picture
Figure 5. Antibiotics Picture
Figure 6. Antispasmodic Picture
Figure 7. Others Picture
Figure 8. Nocturia Revenue Market Share by Application in 2019
Figure 9. Hospital Pharmacies Picture
Figure 10. Retail Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Global Nocturia Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Nocturia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Nocturia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Nocturia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Nocturia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Nocturia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Nocturia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Nocturia Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Nocturia Revenue Market Share in 2019
Figure 21. Global Top 10 Players Nocturia Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Nocturia Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Nocturia Revenue Market Share by Regions (2015-2020)
Figure 25. Global Nocturia Revenue Market Share by Regions in 2018
Figure 26. North America Nocturia Revenue and Growth Rate (2015-2020)
Figure 27. Europe Nocturia Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Nocturia Revenue and Growth Rate (2015-2020)
Figure 29. South America Nocturia Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Nocturia Revenue and Growth Rate (2015-2020)
Figure 31. North America Nocturia Revenue Market Share by Countries (2015-2020)
Figure 32. North America Nocturia Revenue Market Share by Countries in 2019
Figure 33. USA Nocturia Revenue and Growth Rate (2015-2020)
Figure 34. Canada Nocturia Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Nocturia Revenue and Growth Rate (2015-2020)
Figure 36. Europe Nocturia Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Nocturia Revenue Market Share by Countries in 2019
Figure 38. Germany Nocturia Revenue and Growth Rate (2015-2020)
Figure 39. UK Nocturia Revenue and Growth Rate (2015-2020)
Figure 40. France Nocturia Revenue and Growth Rate (2015-2020)
Figure 41. Russia Nocturia Revenue and Growth Rate (2015-2020)
Figure 42. Italy Nocturia Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Nocturia Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Nocturia Revenue Market Share by Countries in 2019
Figure 45. China Nocturia Revenue and Growth Rate (2015-2020)
Figure 46. Japan Nocturia Revenue and Growth Rate (2015-2020)
Figure 47. Korea Nocturia Revenue and Growth Rate (2015-2020)
Figure 48. India Nocturia Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Nocturia Revenue and Growth Rate (2015-2020)
Figure 50. South America Nocturia Revenue Market Share by Countries (2015-2020)
Figure 51. South America Nocturia Revenue Market Share by Countries in 2019
Figure 52. Brazil Nocturia Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Nocturia Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Nocturia Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Nocturia Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Nocturia Revenue and Growth Rate (2015-2020)
Figure 57. UAE Nocturia Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Nocturia Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Nocturia Revenue and Growth Rate (2015-2020)
Figure 60. Global Nocturia Revenue Share by Type (2015-2020)
Figure 61. Global Nocturia Revenue Share by Type in 2019
Figure 62. Global Nocturia Market Share Forecast by Type (2021-2025)
Figure 63. Global Anticholinergic Drugs Revenue Growth Rate (2015-2020)
Figure 64. Global Desmopressin Revenue Growth Rate (2015-2020)
Figure 65. Global Antibiotics Revenue Growth Rate (2015-2020)
Figure 66. Global Antispasmodic Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Nocturia Revenue Share by Application (2015-2020)
Figure 69. Global Nocturia Revenue Share by Application in 2019
Figure 70. Global Nocturia Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 72. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 73. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 74. Global Nocturia Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Nocturia Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Nocturia Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Nocturia Revenue Market Forecast (2021-2025)
Figure 78. Europe Nocturia Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Nocturia Revenue Market Forecast (2021-2025)
Figure 80. South America Nocturia Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Nocturia Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
抗コリン薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Anticholinergic Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …- 抗生物質薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Antibiotics Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antibiotics Drugs market re…
- β-ラクタム系抗生剤の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Beta-Lactam Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- バーター症候群薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Bartter Syndrome Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bartter Syndrome Drugs…
- OTC外用薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global OTC Topical Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The OTC Topical Drugs market re…